• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受5-氟尿嘧啶治疗的患者中心绞痛的高发病率。一项针对102名患者的计划监测研究。

High incidence of angina pectoris in patients treated with 5-fluorouracil. A planned surveillance study with 102 patients.

作者信息

Wacker Annette, Lersch Christian, Scherpinski Ute, Reindl Laurence, Seyfarth Melchior

机构信息

I. Medizinische Klinik und Deutsches Herzzentrum, Klinikum rechts der Isar, Technische Universität München, München, Deutschland.

出版信息

Oncology. 2003;65(2):108-12. doi: 10.1159/000072334.

DOI:10.1159/000072334
PMID:12931015
Abstract

OBJECTIVE

Angina pectoris, arrhythmic sudden death and myocardial infarction, all these cardiac events have occasionally been reported during 5-fluorouracil (5-FU) chemotherapy. Underlying mechanisms leading to these events are unknown; damage to the myocytes or vasospasms have been discussed.

METHODS

102 consecutive and unselected patients were monitored with 12-lead ECG, echocardiography and radionuclide ventriculography prior to the first cycle of 5-FU chemotherapy and 3 months from baseline.

RESULTS

19% of the patients developed reversible symptoms of angina pectoris during treatment which lasted up to 12 h after cessation of the infusion. Most of the 19 patients showed corresponding ECG changes. 6 out of the 19 patients with severe angina pectoris had subsequent coronary angiography. In none of these patients the coronary angiography showed coronary artery disease, but it showed low ventricular function (ejection fraction <50%) in 2 patients. The ejection fraction did not increase over time. Arrhythmias were screened for with Holter monitoring during 5-FU chemotherapy. The frequency of bradycardia and ventricular extrasystoles increased significantly (p < 0.05) during treatment compared to arrhythmias in Holter monitoring 3 months later. Furthermore the Qtc time in the ECG 3 months later was significantly prolonged (p < 0.05) compared to baseline values.

CONCLUSIONS

The incidence of angina pectoris in patients during 5-FU treatment seems higher than previously suspected. As myocardial ischemia can be fatal, attentiveness to these symptoms and immediate treatment are crucial.

摘要

目的

心绞痛、心律失常性猝死和心肌梗死,所有这些心脏事件偶尔在5-氟尿嘧啶(5-FU)化疗期间被报道。导致这些事件的潜在机制尚不清楚;已经讨论过对心肌细胞的损伤或血管痉挛。

方法

102例连续且未经选择的患者在5-FU化疗的第一个周期之前以及从基线起3个月时接受12导联心电图、超声心动图和放射性核素心室造影监测。

结果

19%的患者在治疗期间出现可逆性心绞痛症状,在输注停止后持续长达12小时。19例患者中的大多数出现了相应的心电图变化。19例严重心绞痛患者中有6例随后进行了冠状动脉造影。在这些患者中,冠状动脉造影均未显示冠状动脉疾病,但有2例显示心室功能低下(射血分数<50%)。射血分数未随时间增加。在5-FU化疗期间用动态心电图监测筛查心律失常。与3个月后的动态心电图监测中的心律失常相比,治疗期间心动过缓和室性期前收缩的频率显著增加(p<0.05)。此外,与基线值相比,3个月后的心电图中的Qtc时间显著延长(p<0.05)。

结论

5-FU治疗期间患者心绞痛的发生率似乎高于先前的怀疑。由于心肌缺血可能是致命的,对这些症状的关注和及时治疗至关重要。

相似文献

1
High incidence of angina pectoris in patients treated with 5-fluorouracil. A planned surveillance study with 102 patients.接受5-氟尿嘧啶治疗的患者中心绞痛的高发病率。一项针对102名患者的计划监测研究。
Oncology. 2003;65(2):108-12. doi: 10.1159/000072334.
2
Angina induced by 5-fluorouracil infusion in a patient with normal coronaries.
Am Heart Hosp J. 2010 Winter;8(2):E111-2. doi: 10.15420/ahhj.2010.8.2.111.
3
[Coronary artery stenting in the treatment of 5-fluorouracil-induced unstable angina].冠状动脉支架置入术治疗5-氟尿嘧啶所致不稳定型心绞痛
Przegl Lek. 2003;60(1):46-8.
4
Capecitabine may induce coronary artery vasospasm.卡培他滨可能会诱发冠状动脉痉挛。
Hellenic J Cardiol. 2012 Jul-Aug;53(4):320-3.
5
Capecitabine-induced cardiotoxicity: when to suspect? How to manage? A case report.卡培他滨所致心脏毒性:何时怀疑?如何处理?一例病例报告。
J Cardiovasc Med (Hagerstown). 2009 Sep;10(9):722-6. doi: 10.2459/JCM.0b013e32832bb9b1.
6
Electrocardiographic manifestations of 5-fluorouracil cardiotoxicity.5-氟尿嘧啶心脏毒性的心电图表现。
Conn Med. 2005 Aug;69(7):405-6.
7
Acute heart failure after treatment with 5-fluorouracil.5-氟尿嘧啶治疗后出现的急性心力衰竭
J BUON. 2007 Jan-Mar;12(1):113-6.
8
The need for routine monitoring of cardiac function in patients receiving 5-fluorouracil infusion.接受5-氟尿嘧啶输注的患者需要进行心脏功能的常规监测。
Clin J Oncol Nurs. 2014 Jun;18(3):360-2. doi: 10.1188/14.CJON.360-362.
9
Is 5-fluorouracil-induced vasospasm a Kounis syndrome? A diagnostic challenge.5-氟尿嘧啶诱导的血管痉挛是库尼斯综合征吗?一项诊断挑战。
Perfusion. 2011 Nov;26(6):542-5. doi: 10.1177/0267659111410347. Epub 2011 May 31.
10
Ischemia during ambulatory monitoring as a prognostic indicator in patients with stable coronary artery disease.动态监测期间的缺血作为稳定型冠状动脉疾病患者的预后指标。
JAMA. 1997;277(4):318-24.

引用本文的文献

1
Risk factors for fluorouracil-induced cardiotoxicity in patients with gastrointestinal tumor.胃肠道肿瘤患者氟尿嘧啶诱导心脏毒性的危险因素。
Front Cardiovasc Med. 2025 Feb 5;12:1515509. doi: 10.3389/fcvm.2025.1515509. eCollection 2025.
2
Cancer Therapy-Related Cardiac Dysfunction: A Review of Current Trends in Epidemiology, Diagnosis, and Treatment.癌症治疗相关的心脏功能障碍:流行病学、诊断和治疗的当前趋势综述
Biomedicines. 2024 Dec 21;12(12):2914. doi: 10.3390/biomedicines12122914.
3
The Prevalence of 5-Fluorouracil and Capecitabine Cardiotoxicity: A Systematic Review and Meta-Analysis.
5-氟尿嘧啶和卡培他滨心脏毒性的患病率:一项系统评价和荟萃分析
World J Oncol. 2024 Dec;15(6):902-921. doi: 10.14740/wjon1920. Epub 2024 Oct 30.
4
Mechanisms of Myocardial Ischemia in Cancer Patients: A State-of-the-Art Review of Obstructive Versus Non-Obstructive Causes.癌症患者心肌缺血的机制:阻塞性与非阻塞性病因的最新综述
Rev Cardiovasc Med. 2022 Jun 24;23(7):227. doi: 10.31083/j.rcm2307227. eCollection 2022 Jul.
5
Management of Fluoropyrimidine-Induced Cardiac Adverse Outcomes Following Cancer Treatment.癌症治疗后氟嘧啶类药物引起的心脏不良结局的管理。
Cardiovasc Toxicol. 2024 Feb;24(2):184-198. doi: 10.1007/s12012-024-09834-9. Epub 2024 Feb 7.
6
Impaired microvascular reactivity in patients treated with 5-fluorouracil chemotherapy regimens: Potential role of endothelial dysfunction.接受5-氟尿嘧啶化疗方案治疗的患者微血管反应性受损:内皮功能障碍的潜在作用。
Int J Cardiol Heart Vasc. 2023 Nov 17;49:101300. doi: 10.1016/j.ijcha.2023.101300. eCollection 2023 Dec.
7
Cardiogenic shock after 5-fluorouracil administration: a case report and literature review.5-氟尿嘧啶给药后发生的心源性休克:一例病例报告及文献综述
Eur Heart J Case Rep. 2023 Dec 13;7(12):ytad596. doi: 10.1093/ehjcr/ytad596. eCollection 2023 Dec.
8
Redefining the Incidence and Profile of Fluoropyrimidine-Associated Cardiotoxicity in Cancer Patients: A Systematic Review and Meta-Analysis.重新定义癌症患者中氟嘧啶相关心脏毒性的发生率和特征:一项系统评价和荟萃分析
Pharmaceuticals (Basel). 2023 Mar 30;16(4):510. doi: 10.3390/ph16040510.
9
Reintroduction of 5-Fluorouracil Post-cardiac Arrest Secondary to Chemotherapy-Induced Cardiotoxicity.化疗诱导的心脏毒性继发心脏骤停后5-氟尿嘧啶的重新引入
Cureus. 2023 Jan 26;15(1):e34232. doi: 10.7759/cureus.34232. eCollection 2023 Jan.
10
Coronary atherosclerosis and chemotherapy: From bench to bedside.冠状动脉粥样硬化与化疗:从实验台到病床旁
Front Cardiovasc Med. 2023 Jan 19;10:1118002. doi: 10.3389/fcvm.2023.1118002. eCollection 2023.